CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
† Study has passed its completion date and status has not been verified in more than two years.